Introduction
============

Pyogenic granuloma (PG) is a capillary hemangioma first reported in 1897 by Poncet et al. ([@B1]) who called it Botryomycosis humaine; however, in 1904, Hartzell ([@B2]) named it as pyogenic granuloma. PGs generally occur on the skin or in the oral cavity. In contrast, they are rarely reported in the digestive tract ([@B3]).

Small intestinal bleeding is uncommon, accounting for only approximately 4% of all cases of gastrointestinal hemorrhage. Angiodysplasias and tumors are the most common causes of small intestinal bleeding ([@B4]). There are few reports of bleeding caused by PG in the small intestine (35 case reports). We herein describe a series of cases of small intestinal PG, and review the clinical and endoscopic features of our patients and those reported in the literature.

Case Report
===========

Material and Methods
--------------------

This was a single-center, retrospective, observational case series of seven patients with small intestinal PG who were admitted to Keio University Hospital (Tokyo, Japan) between April 2010 and January 2018. We retrospectively collected information from their medical records, including age, sex, comorbidities, symptoms, blood test results, endoscopic data, and treatment.

Results
-------

Among the seven cases, there were eight PGs, as one patient had two metachronous lesions ([Table 1](#t001){ref-type="table"}). The average age was 69.1 years, and there were four men and three women. Anemia, hematochezia, and melena were the main presenting signs. Laboratory examination revealed iron deficiency anemia in many cases, with an average hemoglobin level of 9.14 g/dL. Comorbidities included liver disease in three patients and renal disease in three patients, two of whom were on dialysis. Three patients were taking anticoagulant or antiplatelet drugs.

###### 

Characteristics of 7 Patients with Pyogenic Granulomas.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case\   Age   Sex   Presentation     Hb\      Fe\       MCV\   Ferritin\   Comorbidity                                                                      Use of anticoagulant / antiplatelet drug
  no                                   (g/dL)   (µg/dL)   (fl)   (ng/mL)                                                                                      
  ------- ----- ----- ---------------- -------- --------- ------ ----------- -------------------------------------------------------------------------------- ------------------------------------------
  1       82    F     Hematochezia     8.6      18        93     18          None                                                                             None

  2       68    M     Anemia           11.7     \-        92     \-          Alcoholic liver disease, hepatocellular carcinoma                                None

  3       53    M     Melena, Anemia   7.7      48        84     41          Chronic hepatitis B/C, chronic glomerulonephritis (under hemodialysis), angina   None

  4       66    M     Anemia           13.9     80        91     27          Brain infarction                                                                 Cilostazol

  5       79    M     Anemia           6.6      24        97     40          Atrial fibrillation, heart failure, renal failure, diabetes                      Warfarin

  6       66    F     Hematochezia     8        \-        96     94          Chronic renal failure (under hemodialysis), diabetes                             Low dose aspirin

  7       70    F     Anemia           7.5      36        87     73          Non-alcoholic fatty liver                                                        None
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Hb: hemoglobin, MCV: mean corpuscular volume

The endoscopic characteristics of the eight lesions are summarized in [Table 2](#t002){ref-type="table"}. Three-quarters (6/8) of the PGs were located in the ileum. Patient 3 had two metachronous lesions at different sites, so the second was not thought to be a recurrence of the first polyp, which had been treated with endoscopic mucosal resection (EMR). The average tumor size was 5.9 mm, all PGs were \<10 mm in size and semi-pedunculated. Although single capsule endoscopy (CE) localized the lesions in some cases, in other cases, repeat CE and/or single-balloon enteroscopy (SBE) was needed before the PG was found. CE found the lesions in half of the cases. Six PGs were treated with EMR, and two were surgically resected. In Patient 2, CE detected bleeding from a 5-mm semi-pedunculated polyp in the ileum ([Fig. 1a](#g001){ref-type="fig"}), which was also seen on SBE ([Fig. 1b](#g001){ref-type="fig"}). Endoscopic ultrasonography (EUS) showed that the muscle layer and tumor could not be clearly distinguished ([Fig. 1c](#g001){ref-type="fig"}). Thus, the lesion was tattooed with black ink and was subsequently removed surgically. Surgery was performed in the other case because, when EMR was attempted, the tumor did not lift after submucosal injection. The pathology findings from Patient 2 are shown in [Fig. 2](#g002){ref-type="fig"}. Hematoxylin and Eosin staining showed increased, lobulated, and enlarged capillaries and desquamated epithelium, indicating epithelial erosion ([Fig. 2a](#g002){ref-type="fig"}). Immunostaining with CD34, a marker of vascular endothelial cells, showed capillary proliferation ([Fig. 2b](#g002){ref-type="fig"}).

###### 

Endoscopic Characteristics of the 8 Pyogenic Granulomas.

  Case no   Location   Size (mm)   Form               Treatment   Endoscopic procedures
  --------- ---------- ----------- ------------------ ----------- -----------------------
  1         ileum      6           Semipedunculated   EMR         CE, SBE
  2         ileum      5           Semipedunculated   Surgery     CE, SBE
  3-1       ileum      4           Semipedunculated   EMR         CE, SBE
  3-2       jejunum    6           Semipedunculated   Surgery     CE, SBE
  4         duodenum   8           Semipedunculated   EMR         EGD
  5         ileum      7           Semipedunculated   EMR         CE, SBE
  6         ileum      6           Semipedunculated   EMR         CE, SBE
  7         ileum      5           Semipedunculated   EMR         CE, SBE

SBE: single-balloon enteroscopy, CE: capsule endoscopy, EGD: esophagogastroduodenoscopy

![Endoscopic and ultrasonic images of a pyogenic granuloma (Patient 2). The endoscopic findings from Patient 2. (a) Capsule endoscopy detected bleeding from a 5-mm semi-pedunculated polyp in the ileum. (b) The lesion was also seen on single-balloon enteroscopy. (c) On endoscopic ultrasonography (EUS), the muscle layer and tumor could not be clearly distinguished.](1349-7235-59-0501-g001){#g001}

![Hematoxylin and Eosin (H&E) (a) and anti-CD34 staining (b) of a pyogenic granuloma (Patient 2). The pathology findings from Patient 2 (Low magnification: ×12, High magnification: ×240). (a) H&E staining showed increased, lobulated, and enlarged capillaries and desquamated epithelium, indicating epithelial erosion. (b) Immunostaining with CD34, a marker of vascular endothelial cells, showed capillary proliferation.](1349-7235-59-0501-g002){#g002}

Discussion
==========

PG is a painless, capillary-proliferative lesion that can cause gastrointestinal hemorrhage if located in the digestive tract. It is commonly dark black or bright red, often in the form of stalked or semi-pedunculated polyps. The surface frequently becomes ulcerated. The etiology is thought to be infection or irritation-induced granulation, with 38-70.5% of patients reported to have a history of trauma or infection. In the oral cavity, many patients have a history of chronic irritation from ill-fitting dentures, bites, or sharp teeth. Chronic irritation, such as mucosal damage from fish bones or exposure to gastric acid is reportedly a cause of PG in the gastrointestinal tract. On the other hand, there are also reports of some cases sin which PG developed without trauma or a specifically identified trigger ([@B5]). Histopathologically, PG is a hemangioma characterized by lobule-like growth of capillaries with enlarged vascular endothelial cells and inflammatory cell infiltration in the stroma.

PG in the small intestine is rare. Our search of the PubMed database yielded only 35 reported cases of small intestinal PG ([@B3], [@B5]-[@B37]); ours is the first case series of small bowel PG. The characteristics of the patients in previously reported cases \[male, n=15 (42.8%); female, n=20 (57.1%); average age, 55.6 years (2-86 years)\] are summarized in [Table 3](#t003){ref-type="table"}. Melena was the most frequent presenting sign, followed by anemia. Three patients presented with hematochezia. Data on hemoglobin and comorbidities were available for nearly half of the cases. The average hemoglobin level was 7.96 g/dL. A range of comorbidities were observed, including renal disease (n=3) liver disease (n=3), inflammatory bowel disease (n=2), heart disease (n=2), hypertension (n=1), and brain disease (n=1). As in those reported cases, our series did not indicate that PG was associated with any particular disease.

###### 

Patient Characteristics of 35 Reported Cases of Pyogenic Granuloma.

  Item                              Result
  --------------------------------- -------------------
  Gender (35/35 cases)              
  Male                              15(42.8%)
  Female                            20(57.1%)
  Age (35/35 cases)                 Average 55.6±20.8
  \<40                              7(20.0%)
  40-60                             11(31.4%)
  60-80                             14(40.0%)
  \>80                              3(8.6%)
  Presentation (34/35 cases)        
  Melena                            17(50.0%)
  Anemia                            8(23.5%)
  Hematochezia                      3(8.8%)
  Abdominal pain                    2(5.9%)
  Palpitation                       1(2.9%)
  Fecal occult blood positive       1(2.9%)
  None                              2(5.9%)
  Hemoglobin(g/dL) (18/35 cases)    Average 7.96±3.17
  \<6                               5(27.8%)
  6-8                               5(27.8%)
  8-10                              4(22.2%)
  \>10                              4(22.2%)
  Comorbidities (18/35 cases)       
  Renal disease                     3
  Liver disease                     3
  IBD(Inflammatory bowel disease)   2
  Heart disease                     2
  Hypertension                      1
  Brain disease                     1
  None                              6

[Table 4](#t004){ref-type="table"} summarizes the tumor characteristics in the reported cases. The most common location was in the ileum \[n=21 (60.0%)\], followed by the jejunum \[n=11 (31.4%)\] and the duodenum \[n=3 (8.6%)\]. The median tumor size was 10.0 mm (3-60 mm), with no particular form predominating \[sessile polyps, n=10 (34.5%), semi-pedunculated polyps, n=10 (37.9%), and pedunculated polyps, n=8 (27.6%)\]. Surgery was performed in 23 cases (65.7%), while EMR was performed in 9 (25.7%). The endoscopic and morphologic characteristics of our case series were similar to those reported in the literature; however, we were able to remove the lesion endoscopically in the majority of our patients. Although there is no guideline on the endoscopic resection of small intestinal polyps, semi-pedunculated- or pedunculated-type PG without a non-lifting sing is considered to be an indication for endoscopic treatment, because the risk of perforation is relatively low. In symptomatic patients, such as those with occult and overt obscure gastrointestinal bleeding (OGIB), PG should be removed as a diagnostic treatment. Motohashi et al. ([@B5]) reported a PG that invaded the lower serosal layer via connective tissue in the muscle layers. Thus, preoperative EUS is also recommended so that incomplete endoscopic resection can be avoided. In addition, one of our cases experienced oozing bleeding, which was difficult to stop after a biopsy before endoscopic resection. Since PG is a polyp with abundant capillaries on its surface, in cases in which PG is suspected, EMR should be applied as a diagnostic therapy without biopsy.

###### 

Tumor Characteristics of 35 Reported Cases of Pyogenic Granuloma.

  Characteristics          Result
  ------------------------ --------------------
  Location (35/35 cases)   
  Duodenum                 3(8.6%)
  Jejunum                  11(31.4%)
  Ileum                    21(60.0%)
  Size(mm) (28/35 cases)   Median 10.0 (3-60)
  \<10                     11(39.3%)
  10-20                    8(28.6%)
  20-30                    5(17.9%)
  \>30                     4(14.3%)
  Form (29/35 cases)       
  Sessile                  10(34.5%)
  Semipedunculated         11(37.9%)
  Pedunculated             8(27.6%)
  Therapy (35/35 cases)    
  Surgery                  23(65.7%)
  EMR                      9(25.7%)
  APC                      1(2.9%)
  Laser therapy            1(2.9%)
  Follow up                1(2.9%)

EMR: endoscopic mucosal resection, APC: argon plasma coagulation

The Japan Gastroenterological Endoscopy Society guidelines for OGIB ([@B38]) recommend dynamic computed tomography (CT) as the initial approach. However, when the source of the hemorrhage is a small lesion such as a PG, it is often not detectable on CT. CT did not demonstrate PG in any of our cases, whereas CE did. Moreover, CE provides a good estimation of the location of the bleeding point in the small intestine, indicating where the treating enteroscope should be inserted. Although CT is effective for detecting small intestinal stenosis, which allows the avoidance of CE retention, small lesions like PG can be difficult to detect without direct visualization with a modality like CE. In our cases, there were more lesions of \<10 mm in size in comparison to previous reports. Thus, we couldn't detect the bleeding sources with CT. Moreover, when CE was performed, half of the first CE examinations did not detect PGs. If the bleeding source cannot be identified by a single CE examination, repeated CE should be considered to obtain a definitive diagnosis. Several studies have reported that if overt bleeding, such as melena or hematochezia, is observed, then urgent CE within 24 hours increased the rate at which the bleeding source was detected from 44.2-56% to 87-92.3% ([@B39]-[@B41]). Consequently, urgent CE is one option to identify OGIB sources.

In conclusion, PG is a possible, albeit rare, cause of OGIB. CE is the modality that is most likely to successfully detect PG. EMR should be the first-line approach in therapy; however, an EUS examination is recommended to minimize the chance of incomplete resection.
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